Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Funding Opportunities

  • Biomarker, Imaging, Quality of Life Studies Funding Program (BIQSFP)
    Support for biomarker, imaging, and quality of life studies with or without Cost-Effectiveness Analysis (CEA) proposals, associated with NCI clinical trial concepts proposed by funded National Clinical Trials Network (NCTN) and Community Clinical Oncology Program (CCOP) Research Bases
  • NCI's Cancer Clinical Investigator Team Leadership Award (CCITLA)

    NCI’s Cancer Clinical Investigator Team Leadership Awards recognize and support outstanding mid-career clinical investigators at NCI-Designated Cancer Centers who participate extensively in NCI-funded collaborative clinical trials and whose leadership, participation and activities promote a culture of successful clinical research. Established in 2009, the intent of these awards is to help retain investigators in academic clinical research settings who are working to improve the lives of people with cancer. This year, 11 investigators nationwide have received the award. Each recipient is a full-time faculty member who is a board certified physician and has practiced medicine three to ten years post-fellowship.

    Each CCITLA recipient was nominated for the award by his/her Cancer Center Director on the basis of qualifications, interests, accomplishments, and motivation, and based upon the nominee's intent and ability to promote a successful clinical research culture and to pursue an academic career in clinical research. The awardees will devote 15 to 20 percent effort to the activities associated with this award, and the sponsoring Cancer Centers have agreed to protect the awardees’ time for these activities. The award provides partial salary support for two years for the awardee to engage in activities and efforts related to the award.

    The 2014 CCITLA awardees will be formally announced by James H. Doroshow, M.D., the NCI Deputy Director for Clinical and Translational Research, at the NCI Clinical Trials and Translational Research Advisory Committee (CTAC) Meeting, on Wednesday, November 12, 2014. Dr. Doroshow’s recognition of the 2014 CCITLA recipients will be videocast live between 9:05 – 9:30 am Eastern Time on November 12, 2014 at The videocast will be archived on the website for viewing at a later time.

  • Other NCI Funding Opportunities